Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK

Background: Skin toxicity is a common adverse event during cetuximab (Cmab) treatment. However, few reports have investigated the correlation between skin toxicity and the efficacy of Cmab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). Methods: We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Uozumi, Shinya, Enokida, Tomohiro, Suzuki, Shinya, Nishizawa, Aya, Kamata, Hayato, Okano, Tomoka, Fujisawa, Takao, Ueda, Yuri, Okano, Susumu, Tahara, Makoto, Yamaguchi, Masakazu
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2018
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300475/
https://ncbi.nlm.nih.gov/pubmed/30619755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00616
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars